Core Viewpoint - Current market conditions raise concerns for retirees about the safety of stock investments, with high valuations and questionable economic conditions making it difficult to find quality investments [1] Group 1: AbbVie - AbbVie, a drugmaker that spun off from Abbott Laboratories in 2013, has consistently paid and grown its dividend, qualifying as a Dividend King with over 50 consecutive years of annual payout increases [4] - The company increased its quarterly dividend from $1.30 in early 2021 to $1.73 today, representing a 33% increase over five years, resulting in a current yield of 3.2% [5] - Despite a high payout ratio exceeding 100% due to earnings volatility from acquisitions, AbbVie has generated nearly $20 billion in free cash flow over the past 12 months, significantly surpassing the $11.5 billion paid in dividends [6] - AbbVie has a diverse product mix and has expanded its pipeline through acquisitions, positioning itself for future growth, with a low beta value of 0.35 indicating stability [7] - AbbVie is considered a solid income investment for both short-term and long-term holding [8] Group 2: Coca-Cola - Coca-Cola, alongside AbbVie, is recognized as a blue-chip stock with strong financials, demonstrating resilience by increasing in value during the market downturn in 2022 [9] - Both companies are classified as Dividend Kings, showcasing excellent track records for raising their dividends [9]